INTERCEPT PHARMACEUTICALS IN

CUSIP: 45845PAA6 Class: NOTE 3.250% 7/0

JPMORGAN CHASE & CO's Holding History (CIK: 0000019617)

Note: Option positions (PUT/CALL) are excluded.

Q1 2021
Shares 181,000 Value ($000) $148 Avg Close — Range —
Q4 2020
Shares 1,569,000 Value ($000) $1,247 Avg Close — Range —
Q3 2020
Shares 1,851,000 Value ($000) $1,490 Avg Close — Range —
Q2 2020
Shares 3,685,000 Value ($000) $2,732 Avg Close — Range —
Q1 2020
Shares 5,480,000 Value ($000) $4,453 Avg Close — Range —
Q4 2019
Shares 5,036,000 Value ($000) $5,104 Avg Close — Range —
Q3 2019
Shares 10,584,000 Value ($000) $9,104 Avg Close — Range —
Q2 2019
Shares 11,383,000 Value ($000) $10,157 Avg Close — Range —
Q1 2019
Shares 11,410,000 Value ($000) $11,245 Avg Close — Range —
Q4 2018
Shares 12,465,000 Value ($000) $11,312 Avg Close — Range —
Q3 2018
Shares 12,373,000 Value ($000) $12,469 Avg Close — Range —
Q2 2018
Shares 12,056,000 Value ($000) $10,006 Avg Close — Range —
Q1 2018
Shares 12,141,000 Value ($000) $9,786 Avg Close — Range —
Q4 2017
Shares 14,847,000 Value ($000) $12,026 Avg Close — Range —
Q3 2017
Shares 13,232,000 Value ($000) $10,397 Avg Close — Range —
Q2 2017
Shares 12,367,000 Value ($000) $12,151 Avg Close — Range —
Q1 2017
Shares 2,764,000 Value ($000) $2,585 Avg Close — Range —
Q4 2016
Shares 9,933,000 Value ($000) $8,953 Avg Close — Range —
Q3 2016
Shares 9,552,000 Value ($000) $10,702 Avg Close — Range —